Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,299 | 383,221 | 128,030 | 393,644 | 595,082 |
| Marketable Securities | 233,281 | 98,956 | 128,519 | N/A | N/A |
| Receivables | 53,917 | 43,768 | 37,818 | 24,166 | 15,392 |
| TOTAL | $367,875 | $536,409 | $315,092 | $437,747 | $628,774 |
| Non-Current Assets | |||||
| PPE Net | 807 | 744 | 1,039 | 1,168 | 162 |
| Investments And Advances | 282,548 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 36,265 | 39,645 | 44,115 | 5,392 | 699 |
| TOTAL | $319,620 | $40,389 | $45,154 | $6,560 | $861 |
| Total Assets | $687,495 | $576,798 | $360,246 | $444,307 | $629,635 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,582 | 7,143 | 11,815 | 13,836 | 8,065 |
| Accrued Expenses | 35,353 | 50,855 | 27,570 | 24,502 | 16,573 |
| TOTAL | $42,935 | $57,998 | $39,385 | $38,338 | $24,638 |
| Non-Current Liabilities | |||||
| Long Term Debt | 110,095 | 108,940 | 75,700 | 69,800 | 75,700 |
| Other Non-Current Liabilities | 7,602 | 8,315 | 8,917 | 0 | 37,743 |
| TOTAL | $117,697 | $117,255 | $84,617 | $69,800 | $113,443 |
| Total Liabilities | $160,632 | $175,253 | $124,002 | $108,138 | $138,081 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 154,569 | 133,184 | 100,306 | 94,961 | 94,020 |
| Common Shares | 405 | 359 | 273 | 265 | 252 |
| Retained earnings | -1,186,234 | -988,702 | -752,945 | -601,860 | -385,653 |
| Other shareholders' equity | 2,714 | 4,213 | 1,493 | -1,497 | 688 |
| TOTAL | $526,863 | $401,545 | $236,244 | $336,169 | $491,554 |
| Total Liabilities And Equity | $687,495 | $576,798 | $360,246 | $444,307 | $629,635 |